Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald J Whitley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|March 2, 2013
CommentaryRonald J Whitley
Clinics in Laboratory Medicine|May 26, 2004
Thyroglobulin: a specific serum marker for the management of thyroid carcinomaRonald J Whitley, Kenneth B Ain
Clinical Chemistry|July 4, 2009
National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summaryDennis J Dietzen, Piero Rinaldo, Ronald J Whitley, et al.
Gynecologic Oncology|April 26, 2003
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigationJames L Wilder, Edward Pavlik, John M Straughn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|March 2, 2013
CommentaryRonald J Whitley
Clinics in Laboratory Medicine|May 26, 2004
Thyroglobulin: a specific serum marker for the management of thyroid carcinomaRonald J Whitley, Kenneth B Ain
Clinical Chemistry|July 4, 2009
National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summaryDennis J Dietzen, Piero Rinaldo, Ronald J Whitley, et al.
Gynecologic Oncology|April 26, 2003
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigationJames L Wilder, Edward Pavlik, John M Straughn, et al.
Pageof 1